These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34659226)

  • 1. Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple Myeloma.
    Ye R; Kundrapu S; Gerson SL; Driscoll JJ; Beck R; Ali N; Landgren O; VanHeeckeren W; Luo G; Kroger N; Caimi P; De Lima M; Malek E
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e213-e220. PubMed ID: 30878316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma.
    Gul Z; Bashir Q; Cremer M; Yusuf SW; Gunaydin H; Arora S; Slone S; Nieto Y; Sherwani N; Parmar S; Shah N; Dinh YT; Hosing CM; Popat UR; Kebriaei P; Shpall EJ; Giralt SA; Champlin RE; Qazilbash MH
    Leuk Lymphoma; 2015 Feb; 56(2):533-5. PubMed ID: 24882259
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation.
    Richter S; Böttcher M; Stoll A; Zeremski V; Völkl S; Mackensen A; Ekici AB; Jacobs B; Mougiakakos D
    Transplant Cell Ther; 2024 Jun; 30(6):628.e1-628.e9. PubMed ID: 38460727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
    Scordo M; Shah GL; Adintori PA; Knezevic A; Devlin SM; Buchan ML; Preston EV; Lin AP; Rodriguez NT; Carino CA; Nguyen LK; Sitner NC; Barasch A; Klang MG; Maloy MA; Mastrogiacomo B; Carlow DC; Schofield RC; Slingerland AE; Slingerland JB; Stein-Thoeringer CK; Lahoud OB; Landau HJ; Chung DJ; van den Brink MRM; Peled JU; Giralt SA
    Cancer; 2022 Nov; 128(21):3850-3859. PubMed ID: 36041227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
    Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
    Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells.
    Cooke RE; Quinn KM; Quach H; Harrison S; Prince HM; Koldej R; Ritchie D
    Front Immunol; 2020; 11():2153. PubMed ID: 33013907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation.
    Santana-Gonçalves M; Malmegrim K; Farge D; Oliveira MC
    Handb Clin Neurol; 2024; 202():75-91. PubMed ID: 39111920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect.
    Ott de Bruin LM; Pico-Knijnenburg I; van Ostaijen-Ten Dam MM; Weitering TJ; Berghuis D; Bredius RGM; Lankester AC; van der Burg M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and the length of time since autologous hematopoietic stem cell transplantation-What is their influence on the immune reconstitution in multiple myeloma patients?
    Popierz-Rydlewska N; Merkiel-Pawłowska S; Łojko-Dankowska A; Komarnicki M; Chalcarz W
    PLoS One; 2023; 18(12):e0295308. PubMed ID: 38060495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh.
    Chandrakasan S; Chandra S; Prince C; Kobrynski LJ; Lucas L; Patel K; Walter J; Buckley RH; Meisel R; Ghosh S; Parikh SH
    Blood Adv; 2022 Jun; 6(12):3751-3755. PubMed ID: 35443026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs utilization as effective factors on hematopoietic stem cell transplantation, its outcomes and prognosis; a comprehensive systematic review.
    Habibollahzadeh N; Yavari S; Mirazimi Y; Aghayan AH; Davoudian A; Rafiee M
    BMC Cancer; 2024 Jul; 24(1):890. PubMed ID: 39048974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy imparts distinct systemic adaptive immune function.
    Demery-Poulos C; Romero R; Xu Y; Arenas-Hernandez M; Miller D; Tao L; Galaz J; Farias-Jofre M; Bhatti G; Garcia-Flores V; Seyerle M; Tarca AL; Gomez-Lopez N
    Am J Reprod Immunol; 2022 Nov; 88(5):e13606. PubMed ID: 35989229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying Human Naïve B Cell Proliferation Kinetics and Differentiation in Controlled In Vitro Cell Culture.
    Farchione AJ; Cheon H; Hodgkin PD; Bryant VL
    Methods Mol Biol; 2024; 2826():167-187. PubMed ID: 39017893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are homeostatic mechanisms aiding the reconstitution of the T-cell pool during lymphopenia in humans?
    Baliu-Piqué M; Tesselaar K; Borghans JAM
    Front Immunol; 2022; 13():1059481. PubMed ID: 36483556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation.
    Kelleher P; Greathead L; Whitby L; Brando B; ; Barnett D; Bloxham D; deTute R; Dunlop A; Farren T; Francis S; Payne D; Scott S; Snowden JA; Sorour Y; Stansfield E; Virgo P; Whitby A
    Cytometry B Clin Cytom; 2024 Jun; ():. PubMed ID: 38940298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives.
    Ar MC; El Fakih R; Gabbassova S; Alhuraiji A; Nasr F; Alsaeed A; Sayinalp N; Marashi M
    Leuk Res; 2023 Oct; 133():107365. PubMed ID: 37643508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torquetenovirus from bronchoalveolar lavage fluid as a biomarker for lung infection among immunocompromised hosts.
    Zhu Z; Wang Y; Ning W; Liu C; Chen C
    Biomark Med; 2024; 18(13-14):581-591. PubMed ID: 38982729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma.
    Yuan S; Chen Y; Liu H
    Ther Adv Hematol; 2024; 15():20406207241237594. PubMed ID: 38481949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation.
    Heck C; Steiner S; Kaebisch EM; Frentsch M; Wittenbecher F; Scheibenbogen C; Hanitsch LG; Nogai A; le Coutre P; Bullinger L; Blau IW; Na IK
    Front Immunol; 2021; 12():736137. PubMed ID: 34659226
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.